What the CEO Experiences
Investors don’t respond
Strategics “keep an eye on you”
Clinicians haven’t heard of you
What’s Actually Happening
No one can explain what you do in a sentence
No evidence anyone is using it
Nothing forcing a decision
What the CEO Experiences
Investors lean in
Strategics move faster
Clinicians reference you
What’s Actually Happening
Belief is formed
Early adoption is visible
Momentum compounds
The difference isn’t the product. It’s whether the market has been engineered to believe.
Define the problem and the Point of View that reframes it. Establish the category so the market knows how to understand you.
Outcome: Confusion collapses into clarity.
Activate innovators & early adopters who challenge the old frame. Turn early wins into proof the category is real.
Outcome: Skepticism converts into belief.
Distribute the narrative through customers, journalists, and ecosystem. Let proof propagate across the market.
Outcome: Belief spreads into momentum.
Align narrative, proof, and distribution.
Demand begins pulling the company forward.
Outcome: Adoption becomes inevitable.
Companies that haven't validated a real market problem yet — this is not a product-market fit exercise.
Teams looking for PR, content production, or campaign execution without strategic ownership
Leaders who want momentum without committing time, point of view, or decision-making authority
Medtech companies that need early market signals — adopter traction, investor interest, or strategic attention — before they scale.
CEOs (founder or hired) who own the narrative, not ones looking to outsource it.
Teams at a real inflection point (fundraise, launch, scale, or strategic visibility) who need momentum before scaling.
Patterns clients have seen after belief takes hold and the market responds.
A pre-revenue medical robotics company prepared for its first major tradeshow with little market recognition.
Multiple strategics arrived at the booth simultaneously, engaging deeply once the narrative and belief were visible.
A TechMed/SaaS CEO relied on outbound fundraising to explain a complex category.
Investor meetings accelerated as VCs began referencing the company’s public point of view and category framing.
Early clinical interest depended on direct outreach and individual champions looking at a new approach to imaging.
A major health system came inbound, led by an early adopter who had already internalized the narrative.
We diagnose where you are in the market lifecycle — using frameworks we've applied across venture-backed medtech, healthcare, and emerging technology markets.
We pressure-test your narrative and signals against what investors, strategics, and early adopters need to see at this stage.
We tell you exactly what the market needs next and whether you're positioned to create it.
By drawing on patterns we’ve seen repeatedly across venture-backed healthcare, medtech, and emerging technology markets.